Compliance in Life Science
Klavs Esbjerg (Epista);Evi Larsen (Epista) and Einar Dyrhauge (AmCham)

Members of our life science stakeholders gathered at the AmCham Loft for a PowerBreakfast session on Compliance in the Life Sciences.

Growth, digitalization, patient-centricity: The Life Science industry is experiencing rapid change, and as the life sciences are conservative industries by nature – efficiencies in compliance are not inherent.

During the roundtable concrete ways to make compliance transparent throughout the entire organization were explored, and preparation measures were discussed on how to embrace impact of new regulations and technologies, keeping the organization in control.

Topic expert Klavs Esbjerg, CEO for Epista Life Science, shared details of Epista's 2017 report Compliance Maturity in the Danish Life Science. The roundtable discussion centered around key report conclusions on balancing best practice compliance, without overtaxing management and regulatory resources.

To download Klavs Esbjerg's presentation, click here

10 Weibel11 Roche04 MSD09 Riskpoint06 DXC Technology02 Lockheed Martin03 Copenhagen Marriott08 Bristol-Myers Squibb07 Bayer05 Crowne Plaza
AmCham Denmark · Dag Hammarskjölds Allé 13, 3 · 2100 Copenhagen Ø · Denmark · Phone (+45) 33 932 932 · E-mail: mail@amcham.dk · CVR: 24992314
Copyright© 2010 AmCham Denmark · All Rights Reserved